The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1H-Indol-3-yl)-5-(phenylamino)pyridin-2(1H)-one ID: ALA4776283
PubChem CID: 162642989
Max Phase: Preclinical
Molecular Formula: C19H15N3O
Molecular Weight: 301.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]cc(Nc2ccccc2)cc1-c1c[nH]c2ccccc12
Standard InChI: InChI=1S/C19H15N3O/c23-19-16(17-12-20-18-9-5-4-8-15(17)18)10-14(11-21-19)22-13-6-2-1-3-7-13/h1-12,20,22H,(H,21,23)
Standard InChI Key: KTYFQMCNKIMFBI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
25.9231 -3.3183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9231 -4.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6284 -4.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3378 -4.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3378 -3.3183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6284 -2.9014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6284 -2.0801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.6284 -5.3654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3402 -5.7781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3360 -6.6005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0470 -7.0090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7598 -6.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7572 -5.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0456 -5.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2084 -2.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1237 -2.0947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3176 -1.9270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4627 -3.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9097 -2.6386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1049 -2.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8518 -3.5970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4099 -4.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2127 -4.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
3 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
1 15 1 0
15 16 2 0
16 17 1 0
17 19 1 0
18 15 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 301.35Molecular Weight (Monoisotopic): 301.1215AlogP: 4.27#Rotatable Bonds: 3Polar Surface Area: 60.68Molecular Species: NEUTRALHBA: 2HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.97CX Basic pKa: 0.51CX LogP: 2.82CX LogD: 2.82Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: -0.42
References 1. Visseq,A.; Descheemaeker,A.; Pinto-Pardo,N.; Nauton,L.; Théry,V.; Giraud,F.; Abrunhosa-Thomas,I.; Artola,A.; Anizon,F.; Dallel,R.; Moreau,P.. (2020) Pyridin-2(1H)one derivatives: A possible new class of therapeutics for mechanical allodynia., 187 [PMID:31806536 ] [10.1016/j.ejmech.2019.111917 ]